Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Urinary Obstruction

  • Author: Michael A Policastro, MD; Chief Editor: Erik D Schraga, MD  more...
 
Updated: Feb 23, 2016
 

Practice Essentials

Urinary obstruction is a blockage of the flow of urine out of the body. It is a common cause of acute and chronic renal failure and may result from a wide variety of pathologic processes, intrinsic and extrinsic to the urinary system. Symptoms and signs of obstruction are often mild, occurring over long periods of time and requiring a high index of suspicion for diagnosis. Early recognition and treatment are the keys to preventing renal loss.

Signs and symptoms

Most acute obstructive uropathies are associated with significant pain or abrupt diminution of urine flow; however, chronic urinary obstruction is insidious and requires a careful history and a high index of suspicion. The following may be noted in urinary obstruction:

  • Pain (most common symptom in acute obstruction but typically absent with slowly obstructing conditions)
  • Altered patterns of micturition
  • Acute and chronic renal failure
  • Gross or microscopic hematuria
  • Recurrent urinary tract infection (UTI)
  • New-onset or poorly controlled hypertension secondary to obstruction and increased renin-angiotensin
  • Polycythemia secondary to increased erythropoietin production in the hydronephrotic kidney
  • History of recent gynecologic or abdominal surgery

See Clinical Presentation for more detail.

Diagnosis

Physical exam

The physical examination should include the following:

  • Evaluation for signs of dehydration and intravascular volume depletion; peripheral edema, hypertension, and signs of congestive heart failure from fluid overload may be observed in obstruction from renal failure
  • Palpable kidney or bladder (indicative of a dilated urinary collection system)
  • Rectal or pelvic examination to help determine whether enlargement of pelvic organs is a possible source of urinary obstruction.
  • Examination of the external urethra for phimosis or meatal stenosis

Lab studies

Laboratory studies that may be helpful include the following:

  • Urinalysis and examination of sediment
  • Urinary diagnostic indices (eg, sodium, creatinine, osmolality)
  • Serum electrolytes (sodium, potassium, chloride, bicarbonate), as well as blood urea nitrogen (BUN), creatinine, calcium, phosphate, magnesium, uric acid, and albumin
  • Complete blood count (CBC)

Imaging studies

The goals of any imaging study are to distinguish anatomic etiologies from functional forms of collecting system dilation and to identify the site of blockage. Imaging studies that may be considered include the following:

  • CT – Helical CT (especially without contrast) rapidly is replacing kidneys-ureters-bladder (KUB) x-rays as the first step in the radiologic evaluation of the urinary system
  • MRI - Where available, MRI quickly is becoming the imaging study of choice for urinary obstruction
  • IV pyelography (IVP) – IVP is the procedure of choice for defining the extent and anatomy of obstruction
  • Invasive pyelography – This modality provides the same information as IVP without depending on renal function and can be used when the risks of IVP are considered too great
  • Ultrasonography – This is the procedure of choice for determining the presence of hydronephrosis

See Workup for more detail.

Management

The overriding therapeutic goal is reestablishment of urinary flow. Before specific therapy for obstruction is initiated, the life-threatening complications of obstructive uropathy must be investigated and treatment started.

Once urinary obstruction is under consideration, a transurethral bladder catheter should be placed:

  • If the catheter is properly placed and fluid returns freely, the catheter tip is probably in the bladder, and obstruction above the bladder should be investigated; if a question still remains, imaging studies may be used to establish proper placement
  • If a large PVR volume is noted, obstruction below the bladder should be investigated; catheter drainage should be maintained until the etiology of the obstruction is treated appropriately
  • Urine should be drained completely and rapidly from an obstructed bladder; prolonged urine stasis only predisposes the patient to UTI, urosepsis, and renal failure
  • A urologist should be consulted when a transurethral catheter cannot provide adequate bladder drainage

Calculi are the most common causes of unilateral ureteral obstruction. The following considerations apply:

  • Most small renal calculi pass spontaneously; conservative treatment typically suffices
  • Surgical drainage is necessary only for patients with unrelenting pain, UTI, or persistent obstruction
  • The position of the stone in the ureter determines the preferred method of removal
  • Calculi in the renal pelvis and proximal ureter are amenable to nephroscopy and removal under direct visualization
  • Percutaneous nephrostomy drainage is used for midureteral stones
  • Distal ureter stones can be removed cystoscopically by the use of a loop or basket
  • Extracorporeal shock wave lithotripsy is another viable option for stones in any position in the ureter

Bilateral obstruction of the ureters is almost always asymmetric. The following considerations apply:

  • For midureteral or proximal ureteral obstruction, percutaneous nephrostomy tube placement is indicated
  • For distal obstruction, cystoscopic placement of a ureteral stent can be attempted
  • In case of suspected urosepsis from bilateral ureteral obstruction, bilateral percutaneous nephrostomy tubes must be placed

For obstruction of prostatic origin, medical therapy for benign prostate hypertrophy (BPH) has provided a very successful alternative to surgical therapy but should not be offered to individuals presenting with absolute indications for surgical intervention (eg, recurrent urinary retention, recurrent UTIs, renal insufficiency, bladder calculi, recurrent gross hematuria).[1]

See Treatment and Medication for more detail.

Next

Background

Urinary obstruction is a common cause of acute and chronic renal failure. A wide variety of pathological processes, intrinsic and extrinsic to the urinary system, can cause obstruction. Symptoms and signs of obstruction are often mild, occurring over long periods of time and requiring a high index of suspicion for diagnosis.

Because the degree and duration of obstruction are the chief determinants of renal dysfunction, early recognition and treatment are the keys to preventing renal loss. Urinary obstruction should be viewed as a potentially curable form of kidney disease.

Previous
Next

Pathophysiology

Normal urine production in an adult is about 1.5-2 L/day. Urine flow depends on 3 factors—a pressure gradient from the glomerulus to the Bowman capsule, peristalsis of the renal pelvis and ureters, and the effects of gravity (ie, hydrostatic pressure).

Obstruction of the urinary tract at any level eventually results in elevation of intraluminal ureteral pressure. With prolonged obstruction, ureteral peristalsis is overcome and increased hydrostatic pressures are transmitted directly to the nephron tubules.

As pressures in the proximal tubule and Bowman space increase, glomerular filtration rate (GFR) falls. After 12-24 hours of complete obstruction, intratubular pressure decreases to preobstruction levels. If complete obstruction is not relieved, a depressed GFR is maintained by decreases in renal blood flow mediated by thromboxane A2 and angiotensin II (AII). With continued obstruction, renal blood flow progressively falls, resulting in ischemia and incremental nephron loss. Thus, obstructive uropathy may lead to obstructive nephropathy. Several phases of obstructive nephropathy may be seen, including an early hyperemia and a late vasoconstriction followed by regulation of GFR post obstruction. Recovery of GFR depends on the duration and level of obstruction, preobstruction blood flow, and coexisting medical illness or infection.

Previous
Next

Frequency

No data are available on incidence and prevalence of urinary obstruction in unselected populations. Most epidemiologic studies of obstruction are in selected populations or autopsy studies. In large surveys of elderly men for symptoms of urinary obstruction, a prevalence of 20-35% has been estimated. Most (60%) of the men surveyed with moderately severe to severe symptoms of prostatism did not consult their physicians with these symptoms. Postmortem examinations have found hydronephrosis in 3.8% of adults and 2.0% of children.

Previous
Next

Mortality/Morbidity

Urinary tract obstruction may lead to acute or chronic renal insufficiency or overt kidney failure. Obstruction may lead to a salt-losing nephropathy and urinary concentrating defects. Renal tubular acidosis (RTA) type IV, hyperkalemia, hypomagnesia, and hypophosphatemia are common sequelae of chronic obstruction. Although acute or chronic obstruction may cause urinary tract infection (UTI), other sequelae such as renal calculi, hypertension, and polycythemia are associated with a chronic setting. Ascites is a common sequela of neonatal obstruction syndrome. In cases of acute obstruction, a postobstructive diuresis following relief of the problem is well described.

In adults, incidence and etiology of urinary obstruction vary significantly with the age and sex of the patient. In young and middle-aged men, renal calculi are the most common cause of at least temporary urinary obstruction. Rare cases of obstructive uropathy due to seminal vesicle cyst and appendiceal mucocele have been reported. In young and middle-aged women, gynecologic surgery, pregnancy, and cancers of pelvic organs are important etiologies of obstruction.

Special considerations in pediatric patients include acquired or congential urethral stricture, congenital ureteropelvic junction (UPJ) or ureterovesical junction (UVJ) obstruction, vesicoureteral reflux, and urolithiasis.

After age 60 years, urinary obstruction is most common in men secondary to prostatic hypertrophy; prostate cancer accounts for occasional cases.

Previous
 
 
Contributor Information and Disclosures
Author

Michael A Policastro, MD Assistant Professor of Emergency Medicine, Fellow in Medical Toxicology, Department of Emergency Medicine, University of Cincinnati College of Medicine; Consulting Staff, Department of Emergency Medicine, Jewish Hospital, Health Alliance

Michael A Policastro, MD is a member of the following medical societies: American Academy of Clinical Toxicology, American College of Emergency Physicians, American College of Medical Toxicology, Society for Academic Emergency Medicine, Wilderness Medical Society

Disclosure: Nothing to disclose.

Coauthor(s)

Richard H Sinert, DO Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Vice-Chair in Charge of Research, Department of Emergency Medicine, Kings County Hospital Center

Richard H Sinert, DO is a member of the following medical societies: American College of Physicians, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Pilar Guerrero, MD Assistant Professor, Department of Emergency Medicine, John H Stroger Jr Hospital, Cook County Hospital

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Richard H Sinert, DO Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, Research Director, State University of New York College of Medicine; Consulting Staff, Vice-Chair in Charge of Research, Department of Emergency Medicine, Kings County Hospital Center

Richard H Sinert, DO is a member of the following medical societies: American College of Physicians, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Erik D Schraga, MD Staff Physician, Department of Emergency Medicine, Mills-Peninsula Emergency Medical Associates

Disclosure: Nothing to disclose.

Additional Contributors

David S Howes, MD Professor of Medicine and Pediatrics, Residency Program Director Emeritus, Section of Emergency Medicine, University of Chicago, University of Chicago, The Pritzker School of Medicine

David S Howes, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

References
  1. Shin SH, Kim JW, Kim JW, Oh MM, Moon du G. Defining the degree of intravesical prostatic protrusion in association with bladder outlet obstruction. Korean J Urol. 2013 Jun. 54(6):369-72. [Medline]. [Full Text].

  2. de la Rosette JJ, Witjes WP, Schafer W, et al. Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-"BPH" study. Neurourol Urodyn. 1998. 17(2):99-108. [Medline].

  3. Goel RH, Unnikrishnan R, Remer EM. Acute Urinary Tract Disorders. Radiol Clin North Am. 2015 Nov. 53 (6):1273-92. [Medline].

  4. Nevo A, Mano R, Livne PM, Sivan B, Ben-Meir D. Urinary retention in children. Urology. 2014 Dec. 84 (6):1475-9. [Medline].

  5. Elhebir ES, Hughes JD, Hilmi SC. Calcium Antagonists Use and Its Association with Lower Urinary Tract Symptoms: A Cross-Sectional Study. PLoS One. 2013. 8(6):e66708. [Medline]. [Full Text].

  6. Christensen J, Ostri P, Frimodt-Moller C, Juul C. Intravesical pressure changes during bladder drainage in patients with acute urinary retention. Urol Int. 1987. 42(3):181-4. [Medline].

  7. Gould F, Cheng CY, Lapides J. Comparison of rapid versus slow decompression of the distended urinary bladder. Investigative urology. 1976 Sep. 14 (2):156-8. [Medline].

  8. Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, et al. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol. 2016 Mar. 69 (3):468-74. [Medline].

  9. Barbosa JA, Kowal A, Onal B, Gouveia E, Walters M, Newcomer J, et al. Comparative evaluation of the resolution of hydronephrosis in children who underwent open and robotic-assisted laparoscopic pyeloplasty. J Pediatr Urol. 2013 Apr. 9(2):199-205. [Medline].

  10. Bartosh SM. Medical management of pediatric stone disease. Urol Clin North Am. 2004 Aug. 31(3):575-87, x-xi. [Medline].

  11. Batlle DC, Arruda JA, Kurtzman NA. Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med. 1981 Feb 12. 304(7):373-80. [Medline].

  12. Becker A, Baum M. Obstructive uropathy. Early Hum Dev. 2006 Jan. 82(1):15-22. [Medline].

  13. Belal M, Abrams P. Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 1: Nonurodynamic approach. J Urol. 2006 Jul. 176(1):22-8. [Medline].

  14. Berrocal T, Lopez-Pereira P, Arjonilla A, Gutierrez J. Anomalies of the distal ureter, bladder, and urethra in children: embryologic, radiologic, and pathologic features. Radiographics. 2002 Sep-Oct. 22(5):1139-64. [Medline].

  15. Bosniak MA, Megibow AJ, Ambos MA, et al. Computed tomography of ureteral obstruction. AJR Am J Roentgenol. 1982 Jun. 138(6):1107-13. [Medline].

  16. Catalano C, Pavone P, Laghi A, et al. MR pyelography and conventional MR imaging in urinary tract obstruction. Acta Radiol. 1999 Mar. 40(2):198-202. [Medline].

  17. Chapple CR, Baert L, Thind P, et al. Tamsulosin 0.4 mg once daily: tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH). The European Tamsulosin Study Group. Eur Urol. 1997. 32(4):462-70. [Medline].

  18. Chevalier RL. Pathogenesis of renal injury in obstructive uropathy. Curr Opin Pediatr. 2006 Apr. 18(2):153-60. [Medline].

  19. Chu J. Genitourinary principles. In: Goldfrank's Toxicologic Emergencies. 8th ed. 2006: 442-56.

  20. Dal Canton A, Corradi A, Stanziale R, et al. Glomerular hemodynamics before and after release of 24-hour bilateral ureteral obstruction. Kidney Int. 1980 Apr. 17(4):491-6. [Medline].

  21. Dalgic A, Boyvat F, Karakayali H, et al. Urologic complications in 1523 renal transplantations: The Baskent University experience. Transplant Proc. 2006 Mar. 38(2):543-7. [Medline].

  22. De Luca GC, Wijdicks EF. Images in clinical medicine. Agitation associated with acute bladder obstruction. N Engl J Med. 2010 Oct 21. 363(17):1656. [Medline].

  23. Decramer S, Wittke S, Mischak H, et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med. 2006 Apr. 12(4):398-400. [Medline].

  24. Djavan B, Marberger M. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol. 1999. 36(1):1-13. [Medline].

  25. Feinfeld DA, Anthony VL. Renal principles. In: Goldfrank's Toxicologic Emergencies. 8th ed. 2006: 427-42.

  26. Gustilo-Ashby AM, Jelovsek JE, Barber MD, et al. The incidence of ureteral obstruction and the value of intraoperative cystoscopy during vaginal surgery for pelvic organ prolapse. Am J Obstet Gynecol. 2006 May. 194(5):1478-85. [Medline].

  27. Hoffman LM, Suki WN. Obstructive uropathy mimicking volume depletion. JAMA. 1976 Nov 1. 236(18):2096-7. [Medline].

  28. Ilbeigi P, Lombardo S, Sadeghi-Nejad H. Unusual cause of obstructive uropathy. Int Urol Nephrol. 2005. 37 (3):505-6. [Medline].

  29. Kessler TM, Gerber R, Burkhard FC, et al. Ultrasound assessment of detrusor thickness in men-can it predict bladder outlet obstruction and replace pressure flow study?. J Urol. 2006 Jun. 175(6):2170-3. [Medline].

  30. Kilby MD, Daniels JP, Khan K. Congenital lower urinary tract obstruction: to shunt or not to shunt?. BJU Int. 2006 Jan. 97(1):6-8. [Medline].

  31. Levin RM, Longhurst PA, Whitbeck C, Korstanje C. The effect of tamsulosin on the response of the rabbit bladder to partial outlet obstruction. Neurourol Urodyn. 2006. 25(1):89-94. [Medline].

  32. Louca G, Liberopoulos K, Fidas A, et al. MR urography in the diagnosis of urinary tract obstruction. Eur Urol. 1999 Feb. 35(2):102-8. [Medline].

  33. Matlaga BR, Assimos DG. Urologic manifestations of nonurologic disease urolithiasis. Urol Clin North Am. 2003 Feb. 30(1):91-9. [Medline].

  34. Misseri R, Rink RC, Meldrum DR, Meldrum KK. Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res. 2004 Jun 15. 119(2):149-59. [Medline].

  35. Moudouni SM, Tligui M, Doublet JD, et al. Laparoscopic excision of seminal vesicle cyst revealed by obstruction urinary symptoms. Int J Urol. 2006 Mar. 13(3):311-4. [Medline].

  36. O'Reilly PH, Lawson RS, Shields RA, Testa HJ. Idiopathic hydronephrosis--the diuresis renogram: a new non-invasive method of assessing equivocal pelvioureteral junction obstruction. J Urol. 1979 Feb. 121(2):153-5. [Medline].

  37. Powers TA, Grove RB, Bauriedel JK, et al. Detection of obstructive uropathy using 99mtechnetium diethylenetriaminepentaacetic acid. J Urol. 1980 Nov. 124(5):588-92. [Medline].

  38. Reynard JM. Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents?. Curr Opin Urol. 2004 Jan. 14(1):13-6. [Medline].

  39. Rodriguez RA. Renal toxicology. In: Occupational & Environmental Medicine. 2nd ed. 1997: 355-67.

  40. Rose JG, Gillenwater JY. Pathophysiology of ureteral obstruction. Am J Physiol. 1973 Oct. 225(4):830-7. [Medline].

  41. Rugo HS, Fischman ML. Occupational cancer. In: Occupational & Environmental Medicine. 2nd ed. 1997: 235-70.

  42. Rule AD, Lieber MM, Jacobsen SJ. Is benign prostatic hyperplasia a risk factor for chronic renal failure?. J Urol. 2005 Mar. 173(3):691-6. [Medline].

  43. Tsai JD, Huang FY, Lin CC, et al. Intermittent hydronephrosis secondary to ureteropelvic junction obstruction: clinical and imaging features. Pediatrics. 2006 Jan. 117(1):139-46. [Medline].

  44. Wille-Gussenhoven MJ, de Bock GH, de Beer-Buijs MJ, et al. Prostate symptoms in general practice: seriousness and inconvenience. Scand J Prim Health Care. 1997 Mar. 15(1):39-42. [Medline].

  45. Woderich R, Fowler CJ. Management of lower urinary tract symptoms in men with progressive neurological disease. Curr Opin Urol. 2006 Jan. 16(1):30-6. [Medline].

  46. Zeidel ML, Pirtskhalaishvili G. Urinary tract obstruction. In: Brenner & Rector's The Kidney. 7th ed. 2004.

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.